How did TEVA's Q4 earnings surprise investors?
4/11/2025 11:11am
Teva Pharmaceutical (TEVA) reported an earnings per share (EPS) surprise of $0.01 for the fiscal quarter ending December 31, 2024, compared to the consensus estimate. This indicates that the company's performance for that quarter was slightly better than expected, potentially due to factors such as cost management, market conditions, or business segment performance.